WHO ICTRP trial
Landiolol on cerebral autoregulation and neurlogical outcome in patients with…
ChiCTR2400093445 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400093445 |
|---|---|
| Public title | Landiolol on cerebral autoregulation and neurlogical outcome in patients with sepsis |
| Scientific title | Landiolol on cerebral autoregulation and neurlogical outcome in patients with sepsis |
| Primary sponsor | The Second Affiliated Hospital of Soochow University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Sepsis |
| Interventions | The landiolol group:Besides standard treatment for sepsis, participants randomised to this arm will receive landiolol. The continuous intravenous infusion of landiolol was started at 1.0 µg/kg/min, increasing every 15 minutes by a step… |
| Registration date | Dec 5, 2024 |
| Target size | The landiolol group:38;The standard group:38 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: